Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome.
Hoeks M., Bagguley T., van Marrewijk C., Smith A., Bowen D., Culligan D., Kolade S., Symeonidis A., Garelius H., Spanoudakis M., Langemeijer S., Roelofs R., Wiegerinck E., Tatic A., Killick S., Panagiotidis P., Stanca O., Hellström-Lindberg E., Cermak J., van der Klauw M., Wouters H., van Kraaij M., Blijlevens N., Swinkels DW., de Witte T., EUMDS Registry Participants .